Irbesartan and Hydrochlorothiazide tablets USP 150 mg recall: Labeling Error
Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES…
Why was Irbesartan and Hydrochlorothiazide tablets USP 150 mg recalled?
Labeling: Incorrect or Missing Lot AND/OR Exp Date.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 24I030, Exp 5/2017
- Product
- Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES…
- Recalling firm
- Teva Pharmaceutical Industries
- Quantity
- 3536 bottles
- Distribution
- Nationwide
- Recall date
- December 23, 2015
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)